PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLaw Debenture Regulatory News (LWDB)

Share Price Information for Law Debenture (LWDB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 889.00
Bid: 890.00
Ask: 893.00
Change: -3.00 (-0.34%)
Spread: 3.00 (0.337%)
Open: 886.00
High: 894.00
Low: 886.00
Prev. Close: 892.00
LWDB Live PriceLast checked at -
Law Debenture Corporation is an Investment Trust

To achieve long term capital growth in real terms and steadily increasing income through investing in a diverse portfolio of investments spread both geographically and by sector.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Declaration

28 Sep 2023 15:30

RNS Number : 0462O
Law Debenture Corp PLC
28 September 2023
 

The Law Debenture Corporation p.l.c.

Second Interim Dividend Announcement

· Declaring a second interim dividend of 7.625 pence per ordinary share payable in October 2023, representing an increase of 5.2% over the prior year's second interim dividend.

· It is the Board's intention for each of the first three interim dividends for 2023 to be equivalent to a quarter of Law Debenture's total 2022 dividend of 30.50 pence per ordinary share.

 

The combination of IPS' steady income and our strong reserves allows Law Debenture to continue executing its 45-year track record of maintaining or increasing its dividend payments.

This dividend will be paid on 26 October 2023 to shareholders on the register at close of business on 6 October 2023. The Corporation's shares will go ex-dividend on 5 October 2023. 

Law Debenture Corporate Services Limited

Corporate Secretary

28 September 2023

 

Contact:

Tulchan Communications

David Allchurch, Guy Bates

Lawdebenture@tulchangroup.com

+44 (0)777 193 7173

 

Notes to Editor

Law Debenture's equity portfolio of investments is managed by James Henderson and Laura Foll of Janus Henderson Investors.

Our objective is to achieve long-term capital growth in real terms and steadily increasing income. The aim is to achieve a higher rate of total return than the FTSE Actuaries All-Share Index Total Return through investing in a diversified portfolio of stocks.

In the last ten years Law Debenture has increased its dividend by more than 100% and outperformed its benchmark, the FTSE Actuaries All-Share Index, by 73%1.

Our leading independent professional services business accounts for c.21% of Law Debenture's NAV but has funded 34% of dividends over the past decade. As a result, our Investment Managers' have the flexibility of selecting strong business models and attractive valuation opportunities, which will continue to position the equity portfolio for future longer-term growth and outperformance.

The Law Debenture Corporation p.l.c. is registered in England, company registration number 00030397. LEI number - 2138006E39QX7XV6PP21

1 Source: Law Debenture's Annual Financial Report for the period ended 31 December 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVPPUAABUPWGWR
Date   Source Headline
17th May 20244:12 pmRNSNet Asset Value(s)
16th May 20245:01 pmRNSNet Asset Value(s)
15th May 20245:42 pmRNSNet Asset Value(s)
14th May 20244:47 pmRNSNet Asset Value(s)
13th May 20244:28 pmRNSDirector/PDMR Shareholding
13th May 20243:42 pmRNSNet Asset Value(s)
10th May 20243:09 pmRNSNet Asset Value(s)
9th May 20245:19 pmRNSNet Asset Value(s)
8th May 20243:00 pmRNSNet Asset Value(s)
7th May 20245:39 pmRNSNet Asset Value(s)
3rd May 20244:59 pmRNSNet Asset Value(s)
2nd May 20242:13 pmRNSNet Asset Value(s)
1st May 20244:20 pmRNSNet Asset Value(s)
30th Apr 20244:50 pmRNSNet Asset Value(s)
29th Apr 20244:50 pmRNSNet Asset Value(s)
26th Apr 20245:05 pmRNSNet Asset Value(s)
25th Apr 20243:17 pmRNSNet Asset Value(s)
24th Apr 20244:54 pmRNSNet Asset Value(s)
23rd Apr 20245:29 pmRNSNet Asset Value(s)
22nd Apr 20242:34 pmRNSNet Asset Value(s)
19th Apr 20245:35 pmRNSNet Asset Value(s)
18th Apr 20243:49 pmRNSNet Asset Value(s)
17th Apr 20245:54 pmRNSNet Asset Value(s)
16th Apr 20245:59 pmRNSDirector/PDMR Shareholding
16th Apr 20244:02 pmRNSDirector/PDMR Shareholding
16th Apr 20243:08 pmRNSNet Asset Value(s)
15th Apr 20246:25 pmRNSDirector/PDMR Shareholding
15th Apr 20244:22 pmRNSNet Asset Value(s)
12th Apr 20243:45 pmRNSNet Asset Value(s)
11th Apr 20243:34 pmRNSNet Asset Value(s)
11th Apr 20241:23 pmRNSPurchase of shares by subsidiary undertaking
10th Apr 20244:29 pmRNSNet Asset Value(s)
9th Apr 20242:19 pmRNSNet Asset Value(s)
9th Apr 202411:40 amRNSDirector/PDMR Shareholding
8th Apr 20241:09 pmRNSNet Asset Value(s)
5th Apr 20242:47 pmRNSNet Asset Value(s)
4th Apr 20245:17 pmRNSNet Asset Value(s)
3rd Apr 20243:47 pmRNSNet Asset Value(s)
2nd Apr 20242:49 pmRNSNet Asset Value(s)
28th Mar 20241:58 pmRNSNet Asset Value(s)
28th Mar 20241:55 pmRNSResult of AGM
27th Mar 20245:32 pmRNSNet Asset Value(s)
26th Mar 20244:44 pmRNSNet Asset Value(s)
25th Mar 20241:42 pmRNSNet Asset Value(s)
22nd Mar 20243:21 pmRNSNet Asset Value(s)
22nd Mar 20243:05 pmRNSAmendment: Net Asset Value(s)
22nd Mar 20247:00 amRNSNet Asset Value(s)
20th Mar 20244:53 pmRNSNet Asset Value(s)
19th Mar 20243:03 pmRNSNet Asset Value(s)
18th Mar 20244:34 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.